Galmed Pharmaceutica (GLMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,043 | 24,159 | 13,021 | 3,097 | 4,156 |
| Marketable Securities | 31,622 | 59,962 | 5,976 | 12,351 | 18,845 |
| Receivables | 827 | 218 | 155 | 284 | 379 |
| Other current assets | 27,938 | 6,067 | 0 | 0 | 0 |
| TOTAL | $76,430 | $90,406 | $19,152 | $15,732 | $23,380 |
| Non-Current Assets | |||||
| PPE Net | 171 | 194 | 491 | 718 | 883 |
| Other Non-Current Assets | 538 | 0 | 0 | 0 | 0 |
| TOTAL | $709 | $194 | $491 | $718 | $883 |
| Total Assets | $77,139 | $90,600 | $19,643 | $16,450 | $24,263 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,934 | 2,706 | 3,310 | 3,485 | 2,541 |
| TOTAL | $6,934 | $2,706 | $3,848 | $4,579 | $2,541 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 538 | 1,094 | N/A |
| Other Non-Current Liabilities | 0 | 0 | 0 | 267 | 177 |
| TOTAL | $352 | $N/A | $N/A | $796 | $177 |
| Total Liabilities | $7,286 | $2,706 | $3,848 | $5,375 | $2,718 |
| Shareholders' Equity | |||||
| Common Shares | 58 | 58 | 40 | 34 | 32 |
| Retained earnings | -106,936 | -86,475 | -76,619 | -64,320 | -47,367 |
| Other shareholders' equity | 35 | -11 | -7 | -85 | -206 |
| TOTAL | $69,853 | $87,894 | $15,795 | $11,075 | $21,545 |
| Total Liabilities And Equity | $77,139 | $90,600 | $19,643 | $16,450 | $24,263 |